HWAM
IDXX icon

Hennion & Walsh Asset Management’s Idexx Laboratories IDXX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$435K Sell
827
-15
-2% -$8.41K 0.01% 783
2026
Q1 		$473K Buy
842
+420
+100% +$269K 0.02% 726
2025
Q4 		$285K Buy
+422
New +$287K 0.01% 844

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Hennion & Walsh Asset Management's IDXX Position: Q2 2026 in Review

Hennion & Walsh Asset Management reduced its Idexx Laboratories (IDXX) stake by 1.8% in Q2 2026, selling an estimated $8.41K and leaving 827 shares worth $435K. The position accounts for 0.01% of the portfolio, ranked #783.

Hennion & Walsh Asset Management first reported a position in IDXX in Q4 2025 and has held it in 3 quarters since. The position peaked at $473K in Q1 2026. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Hennion & Walsh Asset Management held 827 shares of Idexx Laboratories worth $435K as of Q2 2026.
  • Hennion & Walsh Asset Management sold 15 Idexx Laboratories shares in Q2 2026, an estimated $8.41K.
  • Idexx Laboratories made up 0.01% of Hennion & Walsh Asset Management's portfolio in Q2 2026, its #783 holding.
  • Hennion & Walsh Asset Management first reported a position in Idexx Laboratories in Q4 2025 and has held it in 3 quarters since.
  • Hennion & Walsh Asset Management's Idexx Laboratories position peaked at $473K in Q1 2026.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.